These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36863545)

  • 1. Lipid-based nanoparticles: Enhanced cellular uptake via surface thiolation.
    Knoll P; Francesco Racaniello G; Laquintana V; Veider F; Saleh A; Seybold A; Denora N; Bernkop-Schnürch A
    Int J Pharm; 2023 Mar; 635():122753. PubMed ID: 36863545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiolation of non-ionic surfactants for the development of lipid-based mucoadhesive drug delivery systems.
    Racaniello GF; Knoll P; Jörgensen AM; Arduino I; Laquintana V; Lopedota AA; Bernkop-Schnürch A; Denora N
    Eur J Pharm Biopharm; 2022 Oct; 179():95-104. PubMed ID: 36058444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
    Li H; Chen M; Su Z; Sun M; Ping Q
    Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S-Protected thiolated nanostructured lipid carriers exhibiting improved mucoadhesive properties.
    Arshad S; Masood-Ur-Rehman ; Hussain Asim M; Nazir I; Shahzadi I; Mousli M; Bernkop-Schnürch A
    Int J Pharm; 2020 Sep; 587():119690. PubMed ID: 32738459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanostructured lipid carriers loaded with simvastatin: effect of PEG/glycerides on characterization, stability, cellular uptake efficiency and in vitro cytotoxicity.
    Safwat S; Ishak RAH; Hathout RM; Mortada ND
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1112-1125. PubMed ID: 28276784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol.
    Qi R; Li YZ; Chen C; Cao YN; Yu MM; Xu L; He B; Jie X; Shen WW; Wang YN; van Dongen MA; Liu GQ; Banaszak Holl MM; Zhang Q; Ke X
    J Control Release; 2015 Jul; 210():160-8. PubMed ID: 26003044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Charge converting nanostructured lipid carriers containing a cell-penetrating peptide for enhanced cellular uptake.
    Knoll P; Hörmann N; Nguyen Le NM; Wibel R; Gust R; Bernkop-Schnürch A
    J Colloid Interface Sci; 2022 Dec; 628(Pt A):463-475. PubMed ID: 35932682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanostructured lipid carriers with exceptional gastrointestinal stability and inhibition of P-gp efflux for improved oral delivery of tilmicosin.
    Zhang Q; Yang H; Sahito B; Li X; Peng L; Gao X; Ji H; Wang L; Jiang S; Guo D
    Colloids Surf B Biointerfaces; 2020 Mar; 187():110649. PubMed ID: 31767412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH-sensitive PEGylation of RIPL peptide-conjugated nanostructured lipid carriers: design and in vitro evaluation.
    Kim CH; Sa CK; Goh MS; Lee ES; Kang TH; Yoon HY; Battogtokh G; Ko YT; Choi YW
    Int J Nanomedicine; 2018; 13():6661-6675. PubMed ID: 30425481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced intestinal absorption of curcumin in Caco-2 cell monolayer using mucoadhesive nanostructured lipid carriers.
    Chanburee S; Tiyaboonchai W
    J Biomed Mater Res B Appl Biomater; 2018 Feb; 106(2):734-741. PubMed ID: 28323388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation, characterization, and evaluation of in vitro skin permeation and in vivo pharmacodynamics of surface-charged tripterine-loaded nanostructured lipid carriers.
    Chen Y; Zhou L; Yuan L; Zhang ZH; Liu X; Wu Q
    Int J Nanomedicine; 2012; 7():3023-32. PubMed ID: 22787398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema.
    Gao S; Tian B; Han J; Zhang J; Shi Y; Lv Q; Li K
    Int J Nanomedicine; 2019; 14():6135-6150. PubMed ID: 31447556
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration.
    Song A; Zhang X; Li Y; Mao X; Han F
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoarchitectonics of Layer-by-Layer (LbL) coated nanostructured lipid carriers (NLCs) for Enzyme-Triggered charge reversal.
    Akkuş-Dağdeviren ZB; Fürst A; David Friedl J; Tribus M; Bernkop-Schnürch A
    J Colloid Interface Sci; 2023 Jan; 629(Pt A):541-553. PubMed ID: 36088699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEGylated nanostructured lipid carriers loaded with 10-hydroxycamptothecin: an efficient carrier with enhanced anti-tumour effects against lung cancer.
    Zhang X; Gan Y; Gan L; Nie S; Pan W
    J Pharm Pharmacol; 2008 Aug; 60(8):1077-87. PubMed ID: 18644200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical anesthetic analgesic therapy using the combination of ropivacaine and dexmedetomidine: hyaluronic acid modified long-acting nanostructured lipid carriers containing a skin penetration enhancer.
    Yang Y; Qiu D; Liu Y; Chao L
    Drug Des Devel Ther; 2019; 13():3307-3319. PubMed ID: 31571832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced oral bioavailability of nintedanib esylate with nanostructured lipid carriers by lymphatic targeting: In vitro, cell line and in vivo evaluation.
    Patel P; Patel M
    Eur J Pharm Sci; 2021 Apr; 159():105715. PubMed ID: 33453388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folate-modified, cisplatin-loaded lipid carriers for cervical cancer chemotherapy.
    Zhang G; Liu F; Jia E; Jia L; Zhang Y
    Drug Deliv; 2016 May; 23(4):1393-7. PubMed ID: 26165422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diethylene glycol monoethyl ether-mediated nanostructured lipid carriers enhance
    Zhang H; Guo J; Wang Z; Wang N; Feng N; Zhang Y
    Acta Pharm; 2023 Mar; 73(1):133-143. PubMed ID: 36692464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular interactions of a lipid-based nanocarrier model with human keratinocytes: Unravelling transport mechanisms.
    Silva E; Barreiros L; Segundo MA; Costa Lima SA; Reis S
    Acta Biomater; 2017 Apr; 53():439-449. PubMed ID: 28119111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.